Chronic incurable pulmonary infections are the greatest threat to well-being and longevity for adults with cystic fibrosis (CF). Aggressive antibiotic therapy is required for infectious exacerbations. Knowledge of CF-related antibiotic therapy ensures that the patient receives maximum benefit with decreased likelihood of complications.